Positron Emission Tomography in Coronary Heart Disease

Positron Emission Tomography in Coronary Heart Disease

With advances in scanner technology, postprocessing techniques, and the development of novel positron emission tomography (PET) tracers, the applications of PET for the study of coronary heart disease have been gaining momentum in the last few years. Depending on the tracer and acquisition protocol,...

Full description

Bibliographic Details
Main Authors:	José de Almeida, Sofia Martinho, Lino Gonçalves, Maria Ferreira
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Applied Sciences
Subjects:	positron emission tomography coronary heart disease plaque imaging perfusion imaging viability imaging 18F-sodium fluoride
Online Access:	https://www.mdpi.com/2076-3417/12/9/4704

Similar Items

Quantification of Skeletal Muscle Perfusion in Peripheral Artery Disease Using 18F‐Sodium Fluoride Positron Emission Tomography Imaging
by: Ting‐Heng Chou, et al.
Published: (2024-02-01)

Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography
by: Reindert F. Oostveen, et al.
Published: (2022-06-01)

Preoperative Assessment of Medication-Related Osteonecrosis of the Jaw Using [18F]fluoride Positron Emission Tomography (PET)/CT and [18F]fluorodeoxyglucose PET/MRI in Correlation with Histomorphometry and Micro-CT—A Prospective Comparative Study
by: Christian Philipp Reinert, et al.
Published: (2024-02-01)

Synthesis of 18fluoride-fluorodeoxyglucose and its clinical applications in positron emission tomography/computed tomography
by: Rajeev Kumar, et al.
Published: (2022-09-01)

Quantification of standardised uptake value for ¹⁸F-FDG positron emission tomography in Malaysia
by: Hanafi, Muhammad Hafiz
Published: (2017)

The emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis
by: Silvia Taralli, et al.
Published: (2012-01-01)

<sup>18</sup>F-fluoroethyltyrozine positron emission tomography combined with computed tomography and computed tomography perfusion in complex diagnostic of glial brain tumors
by: A. I. Pronin, et al.
Published: (2020-02-01)

Positron emission tomography tracers for synucleinopathies
by: Jie Xiang, et al.
Published: (2025-01-01)

Positronium lifetime validation measurements using a long-axial field-of-view positron emission tomography scanner
by: William M. Steinberger, et al.
Published: (2024-08-01)

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01)

Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic Cholangiocarcinoma
by: Eiko Nishioka, et al.
Published: (2022-11-01)

Imaging of pain using positron emission tomography
by: Yu‐Peng Zhou, et al.
Published: (2024-06-01)

Possibilities of positron emission tomography in the diagnosis of primary and recurrent ovarian cancer: a review of literature
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

Comparison of <sup>18</sup>F-fluorothymidine Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
by: Mio Mori, et al.
Published: (2022-10-01)

Beyond the Lumen: Molecular Imaging to Unmask Vulnerable Coronary Plaques
by: Geoffrey Currie, et al.
Published: (2025-01-01)

The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia
by: A. S. Chaban, et al.
Published: (2019-06-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer
by: Richard Yuen, et al.
Published: (2022-03-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
by: Salma M. Borg, et al.
Published: (2024-04-01)

Positron emission tomography for phenotyping inflammation of cardiovascular diseases
by: Xiaoyun Luo, et al.
Published: (2024-12-01)

An effective MRI perfusion threshold based workflow to triage additional 18F-FET PET in posttreatment high grade glioma
by: Krishna Ranjith Kadali, et al.
Published: (2025-03-01)

Localization of focus by 18 F-fludeoxyglucose positron emission tomography computed tomography in the definitive diagnosis of infective endocarditis
by: Sathyamurthy Immaneni, et al.
Published: (2020-01-01)

CARDIAC MAGNETIC RESONANCE IMAGING AND POSITRON EMISSION TOMOGRAPHY IN THE PREDICTION OF LEFT VENTRICULAR DYSFUNCTION REVERSIBILITY IN PATIENTS WITH CHRONIC TOTALLY OCCLUDED CORONARY ARTERIES
by: D. V. Ryzhkova, et al.
Published: (2014-02-01)

An overview of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in giant cell arteritis
by: Thomas Thibault, et al.
Published: (2024-10-01)

Ex Vivo Simultaneous H<sub>2</sub><sup>15</sup>O Positron Emission Tomography and Magnetic Resonance Imaging of Porcine Kidneys—A Feasibility Study
by: Maibritt Meldgaard Arildsen, et al.
Published: (2024-08-01)

PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Automated Measurement of Effective Radiation Dose by <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Yujin Eom, et al.
Published: (2024-12-01)

Clinical usefulness of fluorodeoxyglucose-positron emission tomography/computed tomography and carbohydrate antigen 19-9 in patients with periampullary tumors
by: Jeong Eon Kim, et al.
Published: (2019-12-01)

A Short Dynamic Scan Method of Measuring Bone Metabolic Flux Using [<sup>18</sup>F]NaF PET
by: Tanuj Puri, et al.
Published: (2021-10-01)

Future Prospects of Positron Emission Tomography–Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders
by: Young-Don Son, et al.
Published: (2022-05-01)

Fluorodeoxyglucose-positron emission tomography integrated with computed tomography in suspected recurrent cervical cancer
by: Stojiljković Milica, et al.
Published: (2024-01-01)

Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting
by: Giulia Ferrarazzo, et al.
Published: (2021-02-01)

[<sup>18</sup>F] Sodium Fluoride PET Kinetic Parameters in Bone Imaging
by: Tanuj Puri, et al.
Published: (2021-12-01)

Prognostic Significance of the Bone Marrow-to-Aorta Uptake Ratio on 2-Deoxy-2-[<sup>18</sup>F]fluoro-<span style="font-variant: small-caps">d</span>-glucose Positron Emission Tomography/Computed Tomography in Patients with Cholangiocarcinoma
by: Jeong Won Lee, et al.
Published: (2024-04-01)

Prospective Study of Dobutamine Stress Echocardiography in Comparison with 18F-fluorodeoxyglucose Positron Emission Tomography for Myocardial Viability in Ischemic Cardiomyopathy
by: Nuthalapati Rama Kumari, et al.
Published: (2024-12-01)

The role of dynamic, static, and delayed total-body PET imaging in the detection and differential diagnosis of oncological lesions
by: Yaping Wu, et al.
Published: (2024-01-01)

Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure
by: Egle Kazakauskaite, et al.
Published: (2022-03-01)

Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis
by: Xia Zheng, et al.
Published: (2024-01-01)